Call the shots: vaccine cuts imperil global health

Call the shots: vaccine cuts imperil global h...

Up next

2. Against all obstacles

Tocqueville saw America’s faith in its own democracy as a vital force. But these days the majority of Americans think the country is headed in the wrong direction. Can a group of maximum security prisoners in Sing Sing offer a vision of how to get back on track?Guests and HostsJo ...  Show more

1. Game of chance

John Prideaux, The Economist’s US Editor, embarks on a roadtrip to see how America’s democracy is faring in the era of Trump. His companion is a long-dead French aristocrat called Alexis De Tocqueville, author of arguably the best book ever written about America. When Tocqueville ...  Show more

Recommended Episodes

Call the shots: vaccine cuts imperil global health
The Intelligence from The Economist

America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ...  Show more

The human strain: can mpox be contained?
The Intelligence from The Economist

Mpox is spreading fast across Africa, yet public information campaigns are scant and vaccines in short supply. Is a new pandemic in the offing? Strategists are pondering a new potential threat from Russia: the possibility that it could detonate a <a href="https://www.economist ...

  Show more

Rio brand: why Brazil is courting China
The Intelligence from The Economist

Trade ties between <a href="https://www.economist.com/the-americas/2024/11/17/brazil-courts-china-as-its-musk-feud-erupts-again?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term= ...

  Show more

Wary pharma: AstraZeneca sours on UK
The Intelligence from The Economist

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ...  Show more